Explore more publications!

MarCom Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on MarCom Europe.

Press releases published on October 18, 2025

Benjamin Moore’s 2026 Color of the Year Captures Denver’s Bold New Design Era
Barry I. Gold to Present Groundbreaking ‘We’re Overdosed’ Series at Frankfurt Buchmesse 2025
India’s OPM Ventures Taps Global Co-Production Partners At Film London 2025
The Untold Story of America’s Opioid Epidemic Uncovers the Truth Behind the Crisis
KFSHRC Redefines Cancer Care Through Precision, Innovation, and Localized Advanced Therapies
Crypto News (Live): From $0.0075 to $0.50? Blazpay’s AI Presale Heats Up as Solana and BNB Investors Seek New Gains
Free Welcome Bonus No Deposit Required Real Money Online Casino By Cafe Casino
Crypto Casino No Deposit Bonus | Bitcoin Casino No Deposit Bonus 2025 By Cafe Casino
Free Spins No Deposit UK | Real Money Online Casino In UK By Cafe Casino
Fast Payout Casinos 2025: All iGaming Releases Exclusive Update on the Instant Withdrawal Casinos
Sify Technologies to announce Financial Results for Second Quarter FY 2025-26 on Saturday, October 25, 2025
DeFi crypto Mutuum Finance (MUTM) Onboards Over 17,300 Investors With 70% of Phase 6 Allocated
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025
Detailed Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial Presented at 2025 ESMO Congress Demonstrate Potential for Gedatolisib Regimens to be Practice Changing for Patients with HR+/HER2- Advanced Breast Cancer
General Oncology Announces Promising Preliminary Phase 1 Results from SHARON Trial Presented at ESMO 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions